Interestingly, inflammation and mDAMPs synergistically contribute to sarcopenia [56]; for example, mDAMPs can activate the Toll-like receptor (TLR) pathway and trigger NF-κB signaling, thus increasing the expression of IL-6 and TNF-α [57]. Here, TNF is linked to sarcopenia.